Connection

Daniel Judge to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Daniel Judge has written about Clinical Trials, Phase II as Topic.
Daniel Judge
Connection Strength
0.217
Clinical Trials, Phase II as Topic
  1. Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy. Am J Cardiol. 2022 11 15; 183:93-98.
    View in: PubMed
    Score: 0.217
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.